Roger Palframan

He started his journey with a BSc in pharmacology at King’s College London and PhD in immunology at Imperial College London. He went on to become a Wellcome Trust Postdoctoral Research Fellow at Harvard Medical School.

As head of US Research at UCB, he leads UCB’s US research capabilities, including leading the strategic delivery of the company’s global gene therapy research platform and digital transformation. “In my role within the ever-evolving pharmaceutical industry, embracing innovation is not just an option, but a necessity.”